Tag Archives: TIVO

Top 10 Clean Energy Stocks To Own Right Now

One of the richest men in China has made a big bet on an icon of Europe’s automotive industry.

Li Shufu, the billionaire chairman of Chinese car maker Geely (GELYF), invested about $9 billion buying a stake of almost 10% in Daimler (DDAIF), making him the biggest single shareholder in the owner of Mercedes Benz.

Li, who’s estimated to be worth around $18 billion, has said he’s not interested in a takeover of Daimler. It’s unclear exactly what he’s after with such a big investment, but he dropped a big hint that the German company’s engineering is central to his vision.

“In order to succeed and seize the technology highland, one has to have friends, partners, and alliances and adapt a new way of thinking in terms of sharing and united strength,” Li said in a statement over the weekend.

Some analysts suggest Li wants to get his hands on Daimler’s clean energy technology. That could help boost Geely’s competitive position in China’s market for electric vehicles, which is already the world’s biggest.

Top 10 Clean Energy Stocks To Own Right Now: Keryx Biopharmaceuticals, Inc.(KERX)

Advisors’ Opinion:

  • [By Keith Speights]

    There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ: KERX  ) had to say at this week’s Stifel Nicolaus Weisel Healthcare Conference in Boston. A lot was said, but here are the three highlights you’ll want to know about.

  • [By Lisa Levin]

    Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).

  • [By Lisa Levin]

    Keryx Biopharmaceuticals (NASDAQ: KERX) shares shot up 14 percent to $5.17 after the company announced positive top-line results from its pivotal Phase 3 study of ferric citrate for the treatment of iron deficiency anemia in adults with non-dialysis dependent chronic kidney disease.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

Top 10 Clean Energy Stocks To Own Right Now: Amphenol Corporation(APH)

Advisors’ Opinion:

  • [By Darren Williams] Although the entire cannabis space has quietly taken a hit of their own medicine in recent weeks and gone to sleep, don’t think for one second the entire space isn’t going to light up again soon. That’s just what they do, right? However, knowing who the pretenders are and knowing who the contenders are is really the challenge when it’s comes right down to it.
    First, anyone who claims to be a grower or a seller of cannabis can’t for one second ever make it as a public company right now, or can even legally consider being a public company for that matter, so you can scratch any of those right off your list. At least here in the U.S. anyway, because Canada is already well ahead of the curve having legalized it for medicinal purposes already.
    More importantly, full legalization of marijuana in Canada appears to be on track for July 2018, which will make Canada just the second nation in the world after Uruguay to completely legalize the cultivation, sale and possession of the drug for medical and recreational purposes.
    Regardless, the best time to buy any stocks in a hot growth sector is when either everyone has forgotten about them, or when the overall market landscape has turned bearish, which has yet to happen. However, the former seems to be the case for the cannabis space, despite some very favorable state legislation last Fall.
    For now, as long as you have a license issued by Health Canada, you’re good to go, so there are some stocks trading in Canada already who are well on their way to making some green for investors. Canopy Growth Corporation (TSE: WEED), formerly Tweed Marijuana Inc., is a medical marijuana company based in Smiths Falls, Ontario. Aurora Cannabis Inc. (CVE: ACB), which is engaged in the production and sale of medical cannabis. There’s also Aphria Pharmaceutical Company (TSE: APH), which also is engaged in producing and selling medical marijuana through retail sales and wholesale channels.
    There are many more, but those are just a
  • [By Lee Jackson]

    This is the top pick in the sector and has remained a favorite at RBC for some time.Amphenol Corp. (NYSE: APH) is one of the worlds largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.

Top 10 Clean Energy Stocks To Own Right Now: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Raymond James has downgraded Ritchie Bros. Auctioneers Inc (USA) (NYSE: RBA) common stock to Market Perform

    Loop Capital's Betsy Van Hees sees storage, networking, and connectivity as the 3 reasons why Marvell Technology Group Ltd. (NASDAQ: MRVL) will return to top-Line growth. She reiterated her Buy rating and $18 price target. 

  • [By Max Byerly]

    Ritchie Bros. Auctioneers Inc (NYSE:RBA) (TSE:RBA) – Analysts at Jefferies Group boosted their Q2 2018 earnings estimates for Ritchie Bros. Auctioneers in a report issued on Monday, April 9th. Jefferies Group analyst S. Volkmann now expects that the business services provider will earn $0.39 per share for the quarter, up from their prior forecast of $0.37. Jefferies Group has a “Hold” rating and a $30.00 price target on the stock. Jefferies Group also issued estimates for Ritchie Bros. Auctioneers’ Q3 2018 earnings at $0.16 EPS.

Top 10 Clean Energy Stocks To Own Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 agonists in development for a variety of neurological diseases, including Alzheimers disease. Notwithstanding this above, larger scale transactions of course cannot be ruled out, and we note todays market commentary (Fox Business) regarding the potential sale of Valeant Pharmaceuticals International’s (VRX) Bausch & Lomb unit. It is reasonable to assume thatAllergan could be a bidder for this asset, given the companys presence in ophthalmology, as well as CEO Brent Saunders familiarity with the asset (he was the CEO prior to its sale toValeant in 2013 for $8.7bn). At the time of its sale to Valeant, B&L was generating c.$3bn in revenues and growing at a double-digit rate. Current sales of the asset are unclear due to the reporting structure of Valeant, as well as concerns regarding the companys operating/ pricing strategy.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris. Essentially, Dermiras Phase 3 trials of the investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints.

Top 10 Clean Energy Stocks To Own Right Now: TiVo Inc.(TIVO)

Advisors’ Opinion:

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.

Top 10 Clean Energy Stocks To Own Right Now: iShares MSCI Europe Financials Sector Index Fund(EUFN)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

Top 10 Clean Energy Stocks To Own Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Chris Lange]

    Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

  • [By Peter Graham]

    Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

Top 10 Clean Energy Stocks To Own Right Now: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):

Top 10 Clean Energy Stocks To Own Right Now: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

  • [By SEEKINGALPHA.COM]

    SA: You recently published a thesis on Great Canadian Gaming (OTCPK:GCGMF), a Canadian company do you see the Canadian (or another) market as having greater opportunity to uncover hidden value than the U.S.?

Top 10 Clean Energy Stocks To Own Right Now: Rick’s Cabaret International Inc.(RICK)

Advisors’ Opinion:

  • [By Peter Graham]

    After the market closed yesterday, small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q4 2016 earnings with shares falling by mid single digit percentagesin after hours trading. The Company apparently beat expectations on earnings, but fell short of expectations for comps. Likewise, the stock has already had a very good run meaning expectations were super high.Take a look at the following long term chart which shows Dave & Busters Entertainmentsshare performanceascompared to potential peers such as Buffalo Wild Wings (NASDAQ: BWLD) and upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK):

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment being a pretty steady performer up until June while potential peer, upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), took off last yearand Buffalo Wild Wings (NASDAQ: BWLD) has started to fall off:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment doubling in valuewhile potential peer, small cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), began to takeoff last yearand small capBuffalo Wild Wings (NASDAQ: BWLD) has basically been range bound for the last four days:

Top 10 Heal Care Stocks To Buy For 2018

MannKind (MNKD) investors saw Afrezza script sales close out November with an expected recovery from the week prior which was a holiday week. For the week ending December 1st, total Afrezza sales were just over 470 scripts. This number is at the high end of my script projection model. Afrezza sales have spent the bulk of Q4 in the 400 to 500 range vs. the 300 to 400 range that was seen in Q3. Sales are growing in line with my projections, but well below what is needed to impress the street.

Chart Source – Spencer Osborne

The quarter-over-quarter numbers in terms of scripts are showing a Q4 improvement of 19.02% increase over Q3. This is growth, but slower growth than needed. The silver lining is that with new SKUs, each script contains more cartridges and thus more dollars. This dynamic creates a bump in the revenue line. That bump is nice to see, but will not continue to outpace the script growth percentage for very long. Once the channel is filled with the new SKUs, the revenue percentage gains will more closely mirror the percentages we see in scripts. In other words, the average revenue per script will level off in the weeks ahead.

Top 10 Heal Care Stocks To Buy For 2018: Alphabet Inc.(GOOGL)

Advisors’ Opinion:

  • [By Lee Jackson]

    Alphabet Inc. (NASDAQ: GOOGL) had the man at the top of the search giant selling shares this past week. Lawrence Page shed two blocks of 33,332 shares. The first block was priced at $802.65 a share and the second one at $804.92. The total for the combined trades was a huge $53,583,423. The consensus price target for the stock is $966.68. The shares were changing hands on Friday’s close at $807.80.

  • [By Vikram Nagarkar]

    This Bloomberg reportis just one of the many recent reports which suggest that advertisers could take their ad Dollars elsewhere, or bargain hard to bring down ad prices on Facebook. With advertisers growing more wary of Facebook, it won’t come as a surprise ifAlphabet Inc’s (NSDQ:GOOGL)Google, with its massive reach and scale, emerges as a natural alternative for advertisers.However, a deeper look suggests that even Google might not have as much of a squeaky clean image as many believe it does. Quoting from the same Bloomberg post:

  • [By Virendra Singh Chauhan]

    Apple stock is currently trading at a PE multiple of 14.09, in line with the valuation multiples of other hardware companies like HP Inc (NYSE:HPQ) and Qualcomm (NSDQ:QCOM). However, the Apple services segment is significantly different from a ‘hardware’ business, whether in terms of operations or associated cost structure. It would, therefore, be more accurate to evaluate the segment as a services business in order to gauge its ‘value.’ Two popular companies which generate a ton of services revenue are Alphabet (NSDQ:GOOGL) and Facebook (NSDQ:FB).

  • [By Arie Goren]

    Recently, both suppliers of graphics processing units (GPUs) NVIDIA Corporation (NSDQ:NVDA)and Advanced Micro Devices, Inc. (NSDQ:AMD)have signed new collaborations with leading cloud companies to supply their GPUs to accelerate artificial intelligence in the enterprise. NVIDIA has announced a collaboration with tech giants Microsoft Corporation (NSDQ:MSFT)and International Business Machines (NYSE:IBM), while AMD received orders from Alphabet (NSDQ:GOOGL)to supply GPUs for Google cloud platform. Investors might wonder which one of the two companies NVIDIA or AMD is going to win the GPU race to become the primary supplier for artificial intelligence uses. While right now Nvidia dominates the GPU application in AI, in my opinion, there is enough room for both companies to grow in this marker significantly. Therefore, as I see it, to take advantage of the fast-growing deep learning and artificial intelligence market, it is better to invest in shares of both companies.

  • [By The Ticker Tape]

    Last week ended with a string of results from some of the biggest companies in the tech sector. Positive results continued with earnings beats from Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), and Microsoft Corporation (NASDAQ: MSFT). AMZN and GOOG also beat revenue estimates, but MSFT came up shy of Wall Street’s top-line estimates. Tech earnings continue this week with Apple Inc. (NASDAQ: AAPL) reporting fiscal Q2 results after market close tomorrow. 

Top 10 Heal Care Stocks To Buy For 2018: (LVMUY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    (Incidentally, the operating structure and history of growth through smart acquisitions and management is a reminiscent story behind the rise of Bernard Arnault and The Arnault Family Group, which is the majority controlling shareholder in LVMH Mo毛t Hennessy Louis Vuitton S.E. (OTCPK:LVMUY) and Christian Dior SE in the ultra-luxury goods industry.)

Top 10 Heal Care Stocks To Buy For 2018: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

  • [By WWW.KIPLINGER.COM]

    Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.

  • [By Ben Levisohn]

    In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).

Top 10 Heal Care Stocks To Buy For 2018: TiVo Inc.(TIVO)

Advisors’ Opinion:

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.

Top 10 Heal Care Stocks To Buy For 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    MGM Resorts International (NYSE: MGM) is also a top pick for the first quarter, and Merrill Lynch’s price objective of $33.00 was versus a recent price of $28.50. The consensus analyst target price is a tad higher at $33.86.

  • [By JJ Kinahan]

    The earnings parade continues as the Fed wraps up its July meeting. Biotech giant Gilead Sciences, Inc. (NASDAQ: GILD) reports today after market close, and tomorrow morning both Verizon Communications Inc. (NYSE: VZ) and MGM Resorts International (NYSE: MGM) release their second-quarter results.  

  • [By Wayne Duggan]

    According to Deutsche Bank analyst Carlo Santarelli, news that Las Vegas Sands Corp. (NYSE: LVS) may be selling its Sands Bethlehem resort to MGM Resorts International (NYSE: MGM) could be a win-win-win for Sands, MGM and MGM Growth Properties LLC (NYSE: MGP).

Top 10 Heal Care Stocks To Buy For 2018: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

    Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

  • [By Cory Renauer]

    Shares of Agenus Inc (NASDAQ:AGEN), a biopharmaceutical company developing cancer therapies, had fallen about 14.5% as of 3:20 p.m. EST on Wednesday. Investors weren’t too thrilled about its cancer vaccine’s recent clinical trial failure.

Top 10 Heal Care Stocks To Buy For 2018: MEI Pharma, Inc.(MEIP)

Advisors’ Opinion:

  • [By Chris Lange]

    MEI Pharma, Inc. (NASDAQ: MEIP) saw its shares make a solid gain on Thursday after the company received a crucial upgrade from Oppenheimer. Most analysts only issue price targets that are within a range of 5% to 25% for stocks, but this upgrade absolutely blows these small calls out of the water.

Top 10 Heal Care Stocks To Buy For 2018: BiondVax Pharmaceuticals Ltd.(BVXV)

Advisors’ Opinion:

  • [By Chris Lange]

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.

Top 10 Heal Care Stocks To Buy For 2018: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 10 Heal Care Stocks To Buy For 2018: New York & Company Inc.(NWY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of New York & Company, Inc. (NYSE: NWY) got a boost, shooting up 13 percent to $2.31 as the company posted upbeat quarterly results.

    The GEO Group Inc (NYSE: GEO) shares were also up, gaining 19 percent to $23.27. Following Thursday’s Department of Justice news regarding privately-managed prisons, GEO Group dropped on Thursday, but rebounded Friday after issuing a response to the DoJ.

  • [By Monica Gerson]

    New York & Company, Inc. (NYSE: NWY) shares dropped 42 percent to $1.72 after the company reported downbeat Q1 results and issued a weak Q2 forecast.

Stocks Rise As the Fed Raises Rates

U.S. equities climbed again on Wednesday as the Federal Reserve raised interest rates and penciled in another three quarter-point hikes for 2018. Policymakers pointed to an expected pickup in GDP growth, ongoing strength in the labor market and the specter of a big fiscal policy push from the GOP’s tax cut legislation as rationales for their action.

In her post-meeting press conference, Fed chairman Janet Yellen said she expects a pickup in economic growth and business investment and she blamed the lack of wage growth on slow productivity gains. Concerning Bitcoin, she labeled it a highly speculative asset that is playing a very small role in the financial system.

In the end, the Dow Jones Industrial Average gained 0.4%, the S&P 500 lost 0.05%, the NASDAQ Composite gained 0.2% and the Russell 2000 gained 0.6%. Treasury bonds strengthened, the dollar was under pressure, gold gained 0.6% and crude oil lost 0.9%.

investorplace.com/wp-content/uploads/2017/12/indu121317-300×183.jpg 300w, investorplace.com/wp-content/uploads/2017/12/indu121317-768×470.jpg 768w, investorplace.com/wp-content/uploads/2017/12/indu121317-1024×626.jpg 1024w, investorplace.com/wp-content/uploads/2017/12/indu121317-49×30.jpg 49w, investorplace.com/wp-content/uploads/2017/12/indu121317-200×122.jpg 200w, investorplace.com/wp-content/uploads/2017/12/indu121317-400×245.jpg 400w, investorplace.com/wp-content/uploads/2017/12/indu121317-116×71.jpg 116w, investorplace.com/wp-content/uploads/2017/12/indu121317-100×61.jpg 100w, investorplace.com/wp-content/uploads/2017/12/indu121317-82×50.jpg 82w,https://investorplace.com/wp-content/uploads/2017/12/indu121317-78×48.jpg 78w, investorplace.com/wp-content/uploads/2017/12/indu121317-800×489.jpg 800w, investorplace.com/wp-content/uploads/2017/12/indu121317-170×104.jpg 170w” sizes=”(max-width: 600px) 100vw, 600px” />

Breadth was positive with 1.3 advancers for every declining issue while trading volume was 104% of the NYSE’s 30-day average. Consumer staples led the way on a 0.5% gain while financials were the laggards, down 1.3%.

Finisar Corporation (NASDAQ:FNSR) gained 22.8% on the awarding of nearly $400 million from Apple Inc. (NASDAQ:AAPL) to fund the production of optical lenses needed for its Face ID system. Caterpillar Inc. (NYSE:CAT) gained 3.6% on reporting a 26% increase in three-month machinery sales. And Overstock.com Inc (NASDAQ:OSTK) gained 13.9% on reports its founder is exploring options to sell and create a digital property registry based on blockchain technology.

On the downside, TiVo Corp (NASDAQ:TIVO) fell 7.6% on a downgrade from analysts at FBR on its ongoing dispute with a cable operator.

Turning to the economic data, core CPI came in a little soft despite yesterday’s hot PPI reading, suggesting inflation remains a little tepid. Goldman Sachs highlighted that the more-persistent shelter and medical care services components drove the downside. Republicans have already reached a tentative deal on their tax cut plan and plan to hold a vote before Christmas.

Conclusion

investorplace.com/wp-content/uploads/2017/12/121317gld-300×183.jpg 300w, investorplace.com/wp-content/uploads/2017/12/121317gld-768×470.jpg 768w, investorplace.com/wp-content/uploads/2017/12/121317gld-1024×626.jpg 1024w, investorplace.com/wp-content/uploads/2017/12/121317gld-49×30.jpg 49w, investorplace.com/wp-content/uploads/2017/12/121317gld-200×122.jpg 200w, investorplace.com/wp-content/uploads/2017/12/121317gld-400×245.jpg 400w, investorplace.com/wp-content/uploads/2017/12/121317gld-116×71.jpg 116w, investorplace.com/wp-content/uploads/2017/12/121317gld-100×61.jpg 100w, investorplace.com/wp-content/uploads/2017/12/121317gld-82×50.jpg 82w,https://investorplace.com/wp-content/uploads/2017/12/121317gld-78×48.jpg 78w, investorplace.com/wp-content/uploads/2017/12/121317gld-800×489.jpg 800w, investorplace.com/wp-content/uploads/2017/12/121317gld-170×104.jpg 170w” sizes=”(max-width: 600px) 100vw, 600px” />

Keep an eye on what’s happening in the gold market, which has been underperforming lately amid the focus on Bitcoin and the seven-day rally in the U.S. dollar. The GOP’s tax cut plan will pour gasoline on the economy and light a match at a time when output is very near capacity. The job market is tight, with just one unemployed worker for every open position. Small business surveys show difficulty finding qualified help.

All of this suggests wage gains are coming, which will boost inflation measures and end this recent “Goldilocks” scenario of good growth, a dovish Fed and no price pressure. Policymakers are likely to fall behind the curve, which could drive interest into precious metals as the Bitcoin fad fades.

Today’s Trading Landscape:

To see a list of the companies reporting earnings today, click here.

For a list of this week’s economic reports due out, click here.

Anthony Mirhaydari is founder of the Edge (ETFs) and Edge Pro (Options) investment advisory newsletters. Free two- and four-week trial offers have been extended to InvestorPlace readers.

Compare Brokers

Stocks Rise As the Fed Raises Rates

U.S. equities climbed again on Wednesday as the Federal Reserve raised interest rates and penciled in another three quarter-point hikes for 2018. Policymakers pointed to an expected pickup in GDP growth, ongoing strength in the labor market and the specter of a big fiscal policy push from the GOP’s tax cut legislation as rationales for their action.

In her post-meeting press conference, Fed chairman Janet Yellen said she expects a pickup in economic growth and business investment and she blamed the lack of wage growth on slow productivity gains. Concerning Bitcoin, she labeled it a highly speculative asset that is playing a very small role in the financial system.

In the end, the Dow Jones Industrial Average gained 0.4%, the S&P 500 lost 0.05%, the NASDAQ Composite gained 0.2% and the Russell 2000 gained 0.6%. Treasury bonds strengthened, the dollar was under pressure, gold gained 0.6% and crude oil lost 0.9%.

investorplace.com/wp-content/uploads/2017/12/indu121317-300×183.jpg 300w, investorplace.com/wp-content/uploads/2017/12/indu121317-768×470.jpg 768w, investorplace.com/wp-content/uploads/2017/12/indu121317-1024×626.jpg 1024w, investorplace.com/wp-content/uploads/2017/12/indu121317-49×30.jpg 49w, investorplace.com/wp-content/uploads/2017/12/indu121317-200×122.jpg 200w, investorplace.com/wp-content/uploads/2017/12/indu121317-400×245.jpg 400w, investorplace.com/wp-content/uploads/2017/12/indu121317-116×71.jpg 116w, investorplace.com/wp-content/uploads/2017/12/indu121317-100×61.jpg 100w, investorplace.com/wp-content/uploads/2017/12/indu121317-82×50.jpg 82w,https://investorplace.com/wp-content/uploads/2017/12/indu121317-78×48.jpg 78w, investorplace.com/wp-content/uploads/2017/12/indu121317-800×489.jpg 800w, investorplace.com/wp-content/uploads/2017/12/indu121317-170×104.jpg 170w” sizes=”(max-width: 600px) 100vw, 600px” />

Breadth was positive with 1.3 advancers for every declining issue while trading volume was 104% of the NYSE’s 30-day average. Consumer staples led the way on a 0.5% gain while financials were the laggards, down 1.3%.

Finisar Corporation (NASDAQ:FNSR) gained 22.8% on the awarding of nearly $400 million from Apple Inc. (NASDAQ:AAPL) to fund the production of optical lenses needed for its Face ID system. Caterpillar Inc. (NYSE:CAT) gained 3.6% on reporting a 26% increase in three-month machinery sales. And Overstock.com Inc (NASDAQ:OSTK) gained 13.9% on reports its founder is exploring options to sell and create a digital property registry based on blockchain technology.

On the downside, TiVo Corp (NASDAQ:TIVO) fell 7.6% on a downgrade from analysts at FBR on its ongoing dispute with a cable operator.

Turning to the economic data, core CPI came in a little soft despite yesterday’s hot PPI reading, suggesting inflation remains a little tepid. Goldman Sachs highlighted that the more-persistent shelter and medical care services components drove the downside. Republicans have already reached a tentative deal on their tax cut plan and plan to hold a vote before Christmas.

Conclusion

investorplace.com/wp-content/uploads/2017/12/121317gld-300×183.jpg 300w, investorplace.com/wp-content/uploads/2017/12/121317gld-768×470.jpg 768w, investorplace.com/wp-content/uploads/2017/12/121317gld-1024×626.jpg 1024w, investorplace.com/wp-content/uploads/2017/12/121317gld-49×30.jpg 49w, investorplace.com/wp-content/uploads/2017/12/121317gld-200×122.jpg 200w, investorplace.com/wp-content/uploads/2017/12/121317gld-400×245.jpg 400w, investorplace.com/wp-content/uploads/2017/12/121317gld-116×71.jpg 116w, investorplace.com/wp-content/uploads/2017/12/121317gld-100×61.jpg 100w, investorplace.com/wp-content/uploads/2017/12/121317gld-82×50.jpg 82w,https://investorplace.com/wp-content/uploads/2017/12/121317gld-78×48.jpg 78w, investorplace.com/wp-content/uploads/2017/12/121317gld-800×489.jpg 800w, investorplace.com/wp-content/uploads/2017/12/121317gld-170×104.jpg 170w” sizes=”(max-width: 600px) 100vw, 600px” />

Keep an eye on what’s happening in the gold market, which has been underperforming lately amid the focus on Bitcoin and the seven-day rally in the U.S. dollar. The GOP’s tax cut plan will pour gasoline on the economy and light a match at a time when output is very near capacity. The job market is tight, with just one unemployed worker for every open position. Small business surveys show difficulty finding qualified help.

All of this suggests wage gains are coming, which will boost inflation measures and end this recent “Goldilocks” scenario of good growth, a dovish Fed and no price pressure. Policymakers are likely to fall behind the curve, which could drive interest into precious metals as the Bitcoin fad fades.

Today’s Trading Landscape:

To see a list of the companies reporting earnings today, click here.

For a list of this week’s economic reports due out, click here.

Anthony Mirhaydari is founder of the Edge (ETFs) and Edge Pro (Options) investment advisory newsletters. Free two- and four-week trial offers have been extended to InvestorPlace readers.

Compare Brokers

investing basics

The past few days have been utterly painful for shareholders of Frontier Communications (NASDAQ:FTR). After analysts called the company’s dividend into question, shares have fallen sharply — and they have lost almost half of their value since just this January.

Does such a move mean that the company — and its headline-grabbing dividend yield of over 20% — is a buy at today’s prices? Would it be a better bet than putting your money behind a much safer telecom like AT&T (NYSE:T)?

Image source: Getty Images

The answers to these questions aren’t 100% knowable. But we’ll try to examine them by viewing the two companies through three different lenses.

Sustainable competitive advantages

If I had one piece of advice for beginning investors, it would be this: Spend all your time studying sustainable competitive advantages — otherwise known as “moats.” While valuation, industry dynamics, and total addressable markets aren’t unimportant, they pale in comparison with a company’s moat.

investing basics: Preferred Bank(PFBC)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Preferred Bank (PFBC) has surged 54% in the past year but still trades at a modest discount to the median S&P 1500 regional bank, based on both trailing earnings and estimated 2017 profits.

investing basics: iShares MSCI Europe Financials Sector Index Fund(EUFN)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

investing basics: TiVo Inc.(TIVO)

Advisors’ Opinion:

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.

investing basics: Shire plc(SHPG)

Advisors’ Opinion:

  • [By Todd Campbell]

    The partnered portfolio includes Movantik and Adynovate, which are licensed to AstraZeneca (NYSE:AZN) and Shire (NASDAQ:SHPG), respectively.

    Movantik won Food and Drug Administration approval in September 2014 for use in relievingopioid constipation, and Nektar Therapeutics reports that annual prescriptions jumped 270% year over year in 2016. Currently, Movantik is selling at an annualized clip of about $160 million, and according to the licensing agreement, Nektar Therapeutics receives a 20% plus royalty on U.S. sales, plus potential sales milestone payments.

  • [By Ben Levisohn]

    Specialty pharmaceuticals Shire (SHPG) and Mallinckrodt (MNK) soared today following their better-than-expected earnings, while Morgan Stanley worried about Valeant Pharmaceutical International’s (VRX) ability to sell its unwanted assets.

  • [By Max Macaluso and David Williamson]

    At the end of last week, a Bloomberg article revealed that Shire (NASDAQ: SHPG  ) and pharmaceutical giant Sanofi (NYSE: SNY  ) may be circling ViroPharma (NASDAQ: VPHM  ) . The the following video, from The Motley Fool’s health care show Market Checkup, analysts David Williamson and Max Macaluso take a close look at ViroPharma and discuss the recent interest in this small biotech company.